Back to results
US 2012/0083504 A1Published application
Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
AssigneeAcetylon Pharmaceuticals, Inc.
InventorsJohn H. van Duzer, Ralph Mazitschek, Walter Ogier, James E. Bradner, Guoxiang Huang, Dejian Xie, Nan Yu
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6.
Claims4
The compound
- or a pharmaceutically acceptable salt thereof.
The compound of claim 2, wherein the compound is
A pharmaceutical composition comprising the compound
- or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.